MEDICINOVA, INC. Files 8-K for Material Definitive Agreement
Ticker: MNOV · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1226616
| Field | Detail |
|---|---|
| Company | Medicinova INC (MNOV) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $50,000,000, $75,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
Medicinova signed a big deal, filing an 8-K on 12/29/25.
AI Summary
On December 29, 2025, MEDICINOVA, INC. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in La Jolla, CA, filed this 8-K report to disclose this event. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates a significant new contract or partnership for Medicinova, which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can carry inherent risks related to the terms, execution, and potential impact on the company's financial health.
Key Numbers
- 001-33185 — SEC File Number (Identifies the company's filing history with the SEC.)
- 33-0927979 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- MEDICINOVA, INC. (company) — Registrant
- December 29, 2025 (date) — Date of earliest event reported
- La Jolla, CA (location) — Address of principal executive offices
- Delaware (location) — State of incorporation
FAQ
What type of material definitive agreement did Medicinova, Inc. enter into?
The filing indicates Medicinova, Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 29, 2025.
Where are Medicinova, Inc.'s principal executive offices located?
Medicinova, Inc.'s principal executive offices are located at 4275 Executive Square, Suite 300, La Jolla, CA 92037.
What is Medicinova, Inc.'s state of incorporation?
Medicinova, Inc. is incorporated in Delaware.
What is the SEC file number for Medicinova, Inc.?
The SEC file number for Medicinova, Inc. is 001-33185.
Filing Stats: 886 words · 4 min read · ~3 pages · Grade level 10.8 · Accepted 2025-12-30 07:53:12
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share MNOV The Nasdaq
- $50,000,000 — g a maximum aggregate offering price of $50,000,000 (the "Sales Agreement"). Upon deliver
- $75,000 — the Sales Agreement in an amount up to $75,000, in addition to certain ongoing legal e
Filing Documents
- d25180d8k.htm (8-K) — 28KB
- d25180dex11.htm (EX-1.1) — 198KB
- d25180dex51.htm (EX-5.1) — 8KB
- g25180g1230010043605.jpg (GRAPHIC) — 4KB
- g25180g34l77.jpg (GRAPHIC) — 6KB
- g25180g50i47.jpg (GRAPHIC) — 8KB
- g25180g90e70.jpg (GRAPHIC) — 8KB
- 0001193125-25-335917.txt ( ) — 440KB
- mnov-20251229.xsd (EX-101.SCH) — 3KB
- mnov-20251229_lab.xml (EX-101.LAB) — 18KB
- mnov-20251229_pre.xml (EX-101.PRE) — 11KB
- d25180d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Equity Distribution Agreement by and between the Company and Lucid Capital Markets, LLC, dated December 29, 2025. 5.1 Opinion of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP. 23.1 Consent of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDICINOVA, INC. By: /s/ Yuichi Iwaki, M.D., Ph.D. Name: Yuichi Iwaki, M.D., Ph.D. Title: President and Chief Executive Officer Dated: December 29, 2025